EBS - Emergent Biosolutions beats on revenue July, 30 2020 04:39 PM Emergent Biosolutions Inc. Emergent Biosolutions (NYSE:EBS): Q2 Non-GAAP EPS of $1.98; GAAP EPS of $1.73.More news on: Emergent BioSolutions Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...